Overexpression of CIP2A is associated with non-small cell lung cancer.

Silencing CIP2A by siRNA inhibited the proliferation and clonogenic activity of lung cancer cells.

CIP2A expression in Chinese non-small-cell lung cancer patients may be a useful biomarker of biological malignancy

Cox-regression analysis showed that IL-10 and CIP2A mRNA levels may independently predict survival in patients with lung adenocarcinoma, especially in patients with E6-positive tumors

study addressed a novel role of CIP2A in mediating lung cancer progression through interacting with the AKT-mTOR signaling pathway.

CIP2A regulates cancer metabolism and CREB phosphorylation in non-small cell lung cancer

CIP2A is a tumor-associated autoantigen in lung cancer, which promote lung cancer proliferation partially through MKK4/7-JNK signaling pathway.

CIP2A overexpression is associated with lung metastasis in colorectal cancer .